{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T08:40:11Z","timestamp":1756370411856,"version":"3.44.0"},"reference-count":15,"publisher":"BMJ","issue":"5","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2025,5,14]]},"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:p>Borderline clear cell tumours of the ovary are exceedingly rare, with limited cases documented in literature. We present a case of a woman with primary infertility who presented with abnormal uterine bleeding and a history of bilateral endometriotic cysts. Abdominal examination revealed a mass of 17\u00d712\u2009cm. CT imaging showed a heterogeneous solid-cystic mass measuring 16.6\u00d710.8\u2009cm in the right adnexa with elevated cancer antigen 125 (CA-125) levels (761.9\u2009IU\/mL). Staging laparotomy was performed due to high suspicion of malignancy. Intraoperatively, a right ovarian mass of 18\u00d714\u2009cm size, with intact capsule, and a 3\u00d73\u2009cm left ovarian endometriotic cyst were found. Microscopically, the mass showed a multiloculated cyst wall lined by cuboidal epithelium, without significant nuclear atypia or stromal invasion, and was positive for Napsin A. The overall features were suggestive of clear cell borderline tumour. Postoperative CA-125 level was normalised and the patient was placed under regular follow-up.<\/jats:p>","DOI":"10.1136\/bcr-2025-266082","type":"journal-article","created":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T23:25:32Z","timestamp":1748301932000},"page":"e266082","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Clear cell borderline tumour of the ovary: a rare entity"],"prefix":"10.1136","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7300-7401","authenticated-orcid":false,"given":"Kaarthiga Ramalingam","family":"Gopinath","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Jawaharlal Institute of Postgraduate Medical Education & Research, Puducherry, Puducherry, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chitra","family":"Thyagaraju","sequence":"additional","affiliation":[{"name":"Department of Obstetrics & Gynaecology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, Tamil Nadu, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhawana Ashok","family":"Badhe","sequence":"additional","affiliation":[{"name":"Pathology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,5,26]]},"reference":[{"key":"2025082801163386000_18.5.e266082.1","article-title":"Borderline Clear Cell Adenofibroma of the Ovary","volume":"2017","author":"Kleebkaow","year":"2017","journal-title":"Case Rep Pathol"},{"key":"2025082801163386000_18.5.e266082.2","doi-asserted-by":"crossref","unstructured":"Seidman JD . Surface epithelial tumors of the ovary. In: Blaustein\u2019s pathology of the female genital tract. 1.2002.","DOI":"10.1007\/978-1-4614-3165-7_14-3"},{"key":"2025082801163386000_18.5.e266082.3","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0b013e3182534acf"},{"key":"2025082801163386000_18.5.e266082.4","unstructured":"DeLair DF , Kiyokawa T , Kobel M , et al . Clear cell borderline tumour. In: WHO classification of tumours of the female genital tract. 5th edn. International Agency for Research on Cancer, 2020: 63."},{"key":"2025082801163386000_18.5.e266082.5","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.ygyno.2021.06.033","article-title":"Clear cell carcinoma of the ovary: Epidemiology, pathological and biological features, treatment options and clinical outcomes","volume":"162","author":"Gadducci","year":"2021","journal-title":"Gynecol Oncol"},{"key":"2025082801163386000_18.5.e266082.6","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1245\/s10434-021-10776-7","article-title":"Clear Cell Borderline Ovarian Tumor: Clinical Characteristics, Prognosis, and Management","volume":"29","author":"Ricotta","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"2025082801163386000_18.5.e266082.7","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.2002.6711"},{"key":"2025082801163386000_18.5.e266082.8","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejogrb.2025.01.012","article-title":"Clear cell borderline ovarian tumor: A retrospective study and literature review","volume":"306","author":"Liu","year":"2025","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2025082801163386000_18.5.e266082.9","first-page":"230","article-title":"Borderline clear cell adenofibroma of the ovary associated with ovarian endometriosis: a case report","volume":"33","author":"Vasilakaki","year":"2012","journal-title":"Eur J Gynaecol Oncol"},{"key":"2025082801163386000_18.5.e266082.10","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3892\/mco.2021.2237","article-title":"Clear cell borderline tumor without fibromatous component: Pathological and literature review and report of two cases","volume":"14","author":"Hada","year":"2021","journal-title":"Mol Clin Oncol"},{"key":"2025082801163386000_18.5.e266082.11","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19851215)56:12<2922::AID-CNCR2820561233>3.0.CO;2-L"},{"key":"2025082801163386000_18.5.e266082.12","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S1658-3876(10)50026-8","article-title":"Borderline clear cell adenofibroma with extensive hemorrhagic necrosis","volume":"3","author":"Liu","year":"2010","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"2025082801163386000_18.5.e266082.13","first-page":"87","article-title":"Ovarian clear cell adenofibroma of borderline malignancy. A case report","volume":"38","author":"Katsube","year":"1989","journal-title":"Hiroshima J Med Sci"},{"key":"2025082801163386000_18.5.e266082.14","doi-asserted-by":"crossref","first-page":"94","DOI":"10.7150\/jca.2.94","article-title":"Pathogenesis of ovarian clear cell adenofibroma, atypical proliferative (borderline) tumor, and carcinoma: clinicopathologic features of tumors with endometriosis or adenofibromatous components support two related pathways of tumor development","volume":"2","author":"Zhao","year":"2011","journal-title":"J Cancer"},{"key":"2025082801163386000_18.5.e266082.15","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/PGP.0b013e31816b5cff","article-title":"Intraoperative assessment of clear cell carcinoma of the ovary","volume":"27","author":"Stewart","year":"2008","journal-title":"Int J Gynecol Pathol"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2025-266082","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T08:16:44Z","timestamp":1756369004000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2025-266082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":15,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5,26]]},"published-print":{"date-parts":[[2025,5]]}},"alternative-id":["10.1136\/bcr-2025-266082"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2025-266082","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2025,5]]}}}